Docetaxel

Quốc gia: New Zealand

Ngôn ngữ: Tiếng Anh

Nguồn: Medsafe (Medicines Safety Authority)

Thành phần hoạt chất:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Sẵn có từ:

REX Medical Ltd

INN (Tên quốc tế):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Liều dùng:

80 mg/mL

Dạng dược phẩm:

Concentrate for infusion

Thành phần:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Các đơn vị trong gói:

Vial, glass, Diluent, 6 mL

Lớp học:

Prescription

Loại thuốc theo toa:

Prescription

Sản xuất bởi:

Cipla Ltd

Chỉ dẫn điều trị:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Tóm tắt sản phẩm:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Ngày ủy quyền:

2006-06-23